Skip to search formSkip to main contentSkip to account menu

DOTA-Tyr(1)-octreotate

Known as: DOTA-1-Tyr-octreotate, DOTA-1-tyrosyl-octreotate, DOTA-Y1-TATE 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Purpose Combinations of therapies may enhance therapeutic effects without significantly increasing the incidence of adverse… 
Highly Cited
2015
Highly Cited
2015
Abstract Objective: To establish the optimal safe dose of everolimus in combination with 177Lu-octreotate peptide receptor… 
Highly Cited
2014
Highly Cited
2014
Background: The combination of radiopeptide therapy [peptide receptor radionuclide therapy (PRRT)] with radiosensitizing… 
Highly Cited
2014
Highly Cited
2014
Recent studies have highlighted the high sensitivity of PET imaging with 68Ga-labeled octreotide derivatives for the detection… 
Review
2014
Review
2014
Highly Cited
2011
Highly Cited
2011
Peptide receptor radionuclide therapy (PRRT) is an efficient treatment for gastroenteropancreatic neuroendocrine tumors (GEP NETs… 
Review
2010
Review
2010
  • R. Hicks
  • Cancer imaging : the official publication of the…
  • 2010
  • Corpus ID: 16242870
Abstract Imaging of neuroendocrine tumours (NET) poses significant challenges because of the heterogeneous biology of the tumours… 
Review
2010
Review
2010
OBJECTIVE Hypoglycaemia poses a significant management challenge in patients with unresectable functional malignant insulinoma… 
Highly Cited
2001
Highly Cited
2001
We report here the in vivo diagnostic use of a peptide–dye conjugate consisting of a cyanine dye and the somatostatin analog… 
Highly Cited
2001
Highly Cited
2001
Receptor‐targeted scintigraphy using radiolabeled somatostatin analogs such as octreotate is being used with great success to…